The FDA approved a new drug to treat influenza
On Oct. 24, 2018, the U.S. Food and Drug Administration (FDA) announced it had granted approval of Xofluza…
CDC published ACIP’s 2018-19 influenza vaccination recommendations
On Aug. 24, 2018, the Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee’s (ACIP)…
Cue announced $30 million funding contract from BARDA and HHS
On Jul. 12, 2018, Cue Health announced that is had been awarded up to $30 million in base…
CDC | Influenza | Life Science News | Vaccine
CDC published ACIP’s recommendations for use of quadrivalent live attenuated influenza vaccine (LAIV4) in 2018-19 influenza season
On Jun. 8, 2018, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
The American College of Obstetricians and Gynecologists issued a committee opinion on maternal immunization
On Jun. 1, 2018, the American College of Obstetricians and Gynecologists (ACOG) issued a committee opinion on maternal…
Medigen Vaccines and GC Pharma collaborated to commercialize quadrivalent influenza vaccine in Taiwan
On Apr. 23, 2018, Medigen Vaccine Biologics and GC Pharma entered an exclusive distribution agreement for GCC’s quadrivalent…
The American College of Obstetricians and Gynecologists released opinion on influenza vaccination in pregnancy
On Apr. 1, 2018, the American College of Obstetricians and Gynecologists released a committee opinion on influenza vaccination…
FDA | Influenza | Life Science News | Vaccine
FDA approved expanded pediatric age indication for Fluarix Quadrivalent influenza vaccine
On Jan. 11, 2018, the U.S. Food and Drug Administration (FDA) approved an expanded indication for the four-strain…
Biotechnology | CDC | Diagnostics | FDA | Infectious Disease | Influenza | Life Science News | U.S. Congress | Vaccine | Veterinary
Experts decried lack of flu pandemic readiness, commitment
On Jan. 9, 2018, armed with 1940s-vintage flu vaccine technology and supported by only anemic funding for developing…
Biotechnology | CDC | Influenza | Vaccine
CDC published ACIP 2017-18 influenza vaccination recommendations
On Aug. 25, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
Seqirus announced major advances in pandemic preparedness
On Aug. 7, 2017, Seqirus announced that the accelerated development of cell-based manufacturing technology at its state-of-the-art manufacturing…
Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | NIH | Non-Profit Research | Vaccine | Veterinary
HHS Influenza Pandemic Planning Update was published
On Jun. 15, 2017, the U.S. Department of Health and Human Services (HHS) published the nations’s updated Pandemic…
Biotechnology | Disease | Infectious Disease | Influenza | Life Science News | Non-Profit Research | Therapeutics | Vaccine
CDC updated guidelines for use of non-pharmaceutical measures to help prevent spread of pandemic influenza
On Apr. 21, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published updated guidelines for use…
Spread of avian flu noted in China, Korea, Europe
On Dec. 14, 2016, reports from China and South Korea painted a picture of spreading H5N6 avian flu…
FDA approved extending the age range for use of FluLaval Quadrivalent to include children 6 to 35 months of age
On Nov. 18, 2016, the U.S. Food and Drug Administration (FDA) approved extending the age range for use…
Seqirus received FDA approval for AFLURIA® QUADRIVALENT (Influenza Vaccine) for people 18 years of age and older
On Aug. 29, 2016, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved AFLURIA® QUADRIVALENT…
CDC published 2016-17 influenza vaccination recommendations
On Aug. 26, 2016, the U.S. Centers for Disease Control and Prevention (CDC) published 2016-17 influenza vaccination recommendations….
ACIP voted that live attenuated influenza vaccine (LAIV) should not be used during the 2016-2017 flu season
On Jun. 22, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
FDA approved new injectable influenza vaccine, Fluad, for use in people age 65 years and older
On Nov. 25, 2015, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved Fluadâ„¢ (Influenza…
Biotechnology | Disease | Influenza | Life Science News | Plague | Polio | Vaccine | WHO
WHO published “Recommendations on Vaccine Hesitancy” in special issue of the journalï¾ Vaccine
On Aug. 14, 2015, the World Health Organization (WHO) published “Recommendations on Vaccine Hesitancy” in a special issue…
BioCryst’s RAPIVAB(TM) (peramivir injection) received FDA approval for treatment of influenza in adults
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) had approved RAPIVAB (peramivir…
FDA approved quadrivalent formulation of Fluzone Intradermal inactivated influenza vaccine
On Dec. 12, 2014, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
Biotechnology | CDC | Influenza | Life Science News | Non-Profit Research | Radiology | Stem Cell | Vaccine
CDC published ACIP recommendations for prevention and control ofï¾ Haemophilus influenzaeï¾ type b (Hib) ï¾ disease
On Feb. 28, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
Biotechnology | CDC | Infectious Disease | Influenza | Life Science News | Non-Profit Research | Therapeutics | Vaccine
The CDC initiated the Global Heath Security Agenda
On Aug. 1, 2014, the U.S. Centers for Disease Control and Prevention (CDC) initiated the Global Heath Security…
CDC partnered with Public Health laboratories to define optimal size for influenza virologic surveillance
On Jul. 2, 2013, the U.S. Centers for Disease Control and Prevention (CDC) partnered with Association of Public…
ACIP voted to recommend FluBlok influenza vaccine for people age 18 through 49ï¾ with egg allergy
On Jun. 20, 2013, the Advisory Committee on Immunization Practices (ACIP) voted 13 to 0, in favor of…
FDA approved Fluzone as the third quadrivalent influenza vaccine licensed for US use
On Jun. 10, 2013, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
Texas A&M System and GlaxoSmithKline receive U.S. Government approval to establish influenza vaccine facility In Texas
On Mar. 26, 2013, GlaxoSmithKline and the Texas A&M University System announced that the U.S. Department of Health…
FDA approved quadrivalent formulation of Fluarix
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
A milestone in protection from influenza was reached with FDA approval for Novartis to manufacture seasonal influenza vaccine using cell-based technology in a US facility
On Nov. 20, 2012, the FDA approved a seasonal flu vaccine produced by Novartis using animal cell culture…